Screener
MiMedx Group MDXG Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by MiMedx Group in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001376339-26-000071
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other expense, net | (102) | (101) | (270) | (247) |
| (Loss) income before income tax | (17,780) | 13,007 | (33,111) | 21,617 |
| Income tax benefit (provision) | 2,940 | (3,389) | 7,411 | (4,978) |
| Net (loss) income | $(14,840) | $9,618 | $(25,700) | $16,639 |
| Basic net (loss) income per common share | $(0.10) | $0.07 | $(0.17) | $0.11 |
| Diluted net (loss) income per common share | $(0.10) | $0.06 | $(0.17) | $0.11 |
| Weighted average common shares outstanding - basic | 147,795,741 | 147,761,332 | 148,119,083 | 147,518,179 |
| Weighted average common shares outstanding - diluted | 147,795,741 | 149,317,281 | 148,119,083 | 149,529,544 |
Item 1. Financial Statements
FAQ
- What is MiMedx Group's net income?
- MiMedx Group (MDXG) reported net income of -$14.84M in Q2 2026.
- How has MiMedx Group's net income changed year-over-year?
- MiMedx Group's net income decreased by 254.3% year-over-year, from $9.62M to -$14.84M.
- What is the long-term trend for MiMedx Group's net income?
- Over 3 years (2022 to 2025), MiMedx Group's net income has grown at a 17.2% compound annual growth rate (CAGR), from -$30.2M to $48.58M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about MiMedx Group's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude